| | | | | | | | | | | | | | | | | | | | | | |
Ownership Document
|
| Schema Version: X0508 |
| Document Type: 4 |
| Period of Report: 2024- 1/31/05:00 |
| Not Subject to Section 16? No |
| Issuer: |
| Issuer CIK: 1443863 |
| Issuer Name: BioCorRx Inc. |
| Issuer Trading Symbol: BICX |
| Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1539788 |
| | Owner Name: Lucido Louis C. |
| Reporting Owner Address: |
| | Owner Street 1: 2390 EAST ORANGEWOOD AVENUE |
| | Owner Street 2: SUITE 500 |
| | Owner City: ANAHEIM |
| | Owner State: CA |
| | Owner ZIP Code: 92806 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? Yes |
| | Is Officer? Yes |
| | Is Ten Percent Owner? Yes |
| | Is Other? No |
| | Officer Title: President |
| Aff 10b5 One? No |
| Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock, par value $0.001 |
| | Transaction Date: |
| | | Value: 2024- 1/31/05:00 |
| | Deemed Execution Date: |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: A |
| | | Equity Swap Involved? No |
| | | Footnote ID: F1 |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 18,269 |
| | | Transaction Price Per Share: |
| Value: 0 |
| | | Transaction Acquired-Disposed Code: |
| Value: A |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 493,202 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock, par value $0.001 |
| | Transaction Date: |
| | | Value: 2024- 2/29/05:00 |
| | Deemed Execution Date: |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: A |
| | | Equity Swap Involved? No |
| | | Footnote ID: F2 |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 16,892 |
| | | Transaction Price Per Share: |
| Value: 0 |
| | | Transaction Acquired-Disposed Code: |
| Value: A |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 510,094 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Footnotes: |
| Footnote - F1: These shares were issued to Mr. Lucido pursuant to an Executive Service Agreement (the "Agreement"), dated January 5, 2024, by and between BioCorRx Inc. (the "Company") and Mr. Lucido. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), equivalent to $16,666.66 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.80. |
| Footnote - F2: These shares were issued to Mr. Lucido pursuant to the Agreement. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares of Common Stock equivalent to $16,666.66 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.98. |
| Remarks: |
| Owner Signature: |
| Signature Name: /s/ Louis C. Lucido |
| Signature Date: 2024- 3/7/05:00 |
